[1]张列祥,王协峰,何裕超,等.肿瘤组织微小RNA-542-3p、血管细胞黏附分子-1表达特征与脑胶质瘤术后复发的关系及预测价值[J].陕西医学杂志,2025,54(1):132-137.[doi:DOI:10.3969/j.issn.1000-7377.2025.01.027]
　ZHANG Liexiang,WANG Xiefeng,HE Yuchao,et al.Relationship and predictive value of miR-542-3p and VCAM-1 expression characteristics in tumor tissues and postoperative recurrence of brain glioma[J].,2025,54(1):132-137.[doi:DOI:10.3969/j.issn.1000-7377.2025.01.027]
点击复制

肿瘤组织微小RNA-542-3p、血管细胞黏附分子-1表达特征与脑胶质瘤术后复发的关系及预测价值
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
54
期数:
2025年1期
页码:
132-137
栏目:
临床病理
出版日期:
2025-01-05

文章信息/Info

Title:
Relationship and predictive value of miR-542-3p and VCAM-1 expression characteristics in tumor tissues and postoperative recurrence of brain glioma
作者:
张列祥1; 王协峰2 ; 何裕超1; 蔡 畅1 ; 付宪华1; 李 猛1; 徐 进1; 姜 宁1; 陈宏璘1
(1.江苏省人民医院宿迁医院神经外科,江苏 宿迁 223800; 2.江苏省人民医院神经外科,江苏 南京 212028)
Author(s):
ZHANG Liexiang; WANG Xiefeng; HE Yuchao; CAI Chang; FU Xianhua; LI Meng; XU Jin; JIANG Ning; CHEN Honglin
(Neurosurgery Department,Suqian Hospital,Jiangsu Provincial People's Hospital,Suqian 223800,China)
关键词:
胶质瘤;  微小RNA-542-3p;  血管细胞黏附分子-1;  复发;  预测
Keywords:
Glioma;  MicrornA-542-3p;  Vascular cell adhesion molecule-1;  Recurrence;  Forecast
分类号:
R 739.4
DOI:
DOI:10.3969/j.issn.1000-7377.2025.01.027
文献标志码:
A
摘要:
目的:探讨肿瘤组织中微小RNA-542-3p(miR-542-3p)、血管细胞黏附分子-1(VCAM-1)表达与脑胶质瘤手术后复发的关系及其预测价值。方法:选取实施手术治疗的脑胶质瘤患者91例进行临床研究,其中43例患者于术后1年出现术后复发(复发组)、48例患者手术后1年检查未出现复发病灶(非复发组),对比两组第一次手术后病灶组织标本中的miR-542-3p、VCAM-1蛋白表达差异,并分析miR-542-3p、VCAM-1蛋白表达与胶质瘤术后复发的关系及其预测复发的价值。结果:复发组患者脑胶质瘤组织中miR-542-3p表达水平低于非复发组,复发组患者脑胶质瘤组织中VCAM-1蛋白阳性表达率高于非复发组,差异具有统计学意义(均P<0.05); 复发组患者脑胶质瘤组织病理学分级≥Ⅲ级患者占比、低分化患者占比、非全切手术方式患者占比、肿瘤浸润率均高于非复发组,复发组患者术后放化疗患者占比低于非复发组,差异具有统计学意义(均P<0.05)。miR-542-3p表达降低、VCAM-1蛋白阳性表达、手术范围非全切是脑胶质瘤手术后复发的独立危险因素(均P<0.05); miR-542-3p表达、VCAM-1蛋白预测脑胶质瘤手术后复发的曲线下面积AUC值分别为0.784(95%CI:0.690～0.877)、0.725(95%CI:0.621～0.829)。结论:脑胶质瘤组织中miR-542-3p表达、VCAM-1蛋白表达与肿瘤手术后复发有密切关系,用于临床预测有一定的参考价值。
Abstract:
Objective:To investigate the relationship between the expression of micrornA-542-3p(miR-542-3p)and vascular cell adhesion molecule-1(VCAM-1)in tumor tissues and the recurrence of brain glioma after surgery and its predictive value.Methods:A total of 91 patients with glioma undergoing surgical treatment were selected for clinical study,among which 43 patients had postoperative recurrence one year after surgery(relapse group)and 48 patients had no recurrent lesions one year after surgery(non-recurrence group).The expression difference of miR-542-3p and VCAM-1 in lesion tissue samples after the first operation was compared between the two groups,and the relationship between miR-542-3p and VCAM-1 protein expression and postoperative recurrence of glioma was analyzed,as well as the value of predicting recurrence.Results:The expression level of miR-542-3p in brain glioma tissues of patients with recurrence group was lower than that of non-recurrence group,and the positive expression rate of VCAM-1 protein in brain glioma tissues of patients with recurrence group was higher than that of non-recurrence group,with statistical significance(all P<0.05).The proportion of patients with cerebral glioma histopathological grade ≥Ⅲ,the proportion of poorly differentiated patients,the proportion of patients with non-total resection,and the rate of tumor infiltration in the recurrence group were higher than those in the non-recurrence group,and the proportion of patients with postoperative radiotherapy and chemotherapy in the recurrence group was lower than that in the non-recurrence group,with statistical significance(all P<0.05).Decreased expression of miR-542-3p,positive expression of VCAM-1 protein and incomplete surgical resection were independent risk factors for postoperative recurrence of glioma(all P<0.05).The AUC values of miR-542-3p expression and VCAM-1 protein in predicting postoperative glioma recurrence were 0.784(95%CI:0.690～0.877)and 0.725(95%CI:0.621～0.829),respectively.Conclusion:The expression of miR-542-3p and VCAM-1 protein in brain glioma tissue is closely related to tumor recurrence after surgery,which has certain reference value for clinical prediction.

参考文献/References:

[1] 周龙,刘美霞,田仁富,等.脑胶质瘤组织中ZnT1 mRNA、miR-542-3p表达水平与病理特征的关系及对术后复发的预测价值[J].国际检验医学杂志,2023,44(3):280-284,289.
[2] 成军群,李蒉煜,王瑞馨,等.MRI导向立体定向手术对脑胶质瘤疗效和神经肽、免疫细胞因子的影响[J].中南医学科学杂志,2023,51(1):97-99.
[3] 陈新,章诺贝.长链非编码RNA FGD5-AS1 通过 miR-542-3p/GTPBP4对肝癌细胞放射敏感性的影响[J].暨南大学学报(自然科学与医学版),2021,42(2):152-163.
[4] 周俊超,禹萌,肖鹏,等.VCAM-1和粘附分子P-选择素在脑膜瘤中表达及临床意义[J].实用癌症杂志,2020,35(3):382-384,394.
[5] 杨文圣,许相范,化洪中,等.WHO(2016)中枢神经系统肿瘤分类解读(一)[J].诊断病理学杂志,2016,23(9):641-646.
[6] 董留建,王树凯,冯书彬,等.CIP2A、VCAM-1及TRF1在脑胶质瘤中的表达及临床意义[J].分子诊断与治疗杂志,2020,12(11):1570-1573,1577.
[7] YANG K,WU Z,ZHANG H,et al.Glioma targeted therapy:Insight into future of molecular approaches[J].Mol Cancer,2022,21(1):39.
[8] GISINA A,KHOLODENKO I,KIM Y,et al.Glioma stem cells:Novel data obtained by single-cell sequencing[J].Int J Mol Sci,2022,23(22):14224.
[9] 张君臣,徐武华,钟丽.番茄红素调节RAS同源基因家族成员A/Rho相关激酶信号通路对氧化低密度脂蛋白诱导脑血管内皮细胞凋亡的影响[J].实用临床医药杂志,2023,27(22):44-49.
[10] 李红芳,杨绍,曹莫寒,等.姜黄素对高胆固醇血症模型大鼠脑微循环障碍的改善作用及其机制[J].吉林大学学报(医学版),2021,47(1):53-58.
[11] 杨彬,于晶,王亮,等.微小RNA-542-3p在人脑胶质瘤中的表达及其对细胞增殖迁移能力的影响[J].中华实验外科杂志,2019,36(4):759-761.
[12] LI Z,ZHANG P,FENG F,et al.Screening and interaction analysis of key genes in miR-542-3p Over- Expressed osteosarcoma cells by bioinformatics[J].Comb Chem High Throughput Screen,2020,23(5):411-418.
[13] 胡杜鹃,任娟.复发性脑胶质瘤组织TM4SF1 mRNA、ZnT1 mRNA、miR-542-3p表达与细胞增殖侵袭恶性行为的关系及预测预后的效能[J].河北医药,2022,44(10):1465-1469.
[14] KIM J,PARK M W,PARK Y J,et al.miR-542-3p contributes to the HK2-Mediated high glycolytic phenotype in human glioma cells[J].Genes(Basel),2021,12(5):633.
[15] 魏萌萌,吕志坤,李国珍,等.血清血管生成素样蛋白8、血管细胞黏附分子-1水平联合检测对颅内动脉瘤栓塞术后脑血管痉挛的预测价值[J].临床外科杂志,2023,31(12):1133-1136.
[16] 钟杰,曲彦明,韩松,等.血管细胞黏附分子-1增强人脑胶质瘤细胞系迁移和侵袭能力[J].基础医学与临床,2017,37(1):19-24.
[17] 汤奕林,林砺,黄丽,等.脑干胶质瘤病理学分级预测因素及与APT成像的关系研究[J].肿瘤影像学,2024,33(2):150-155.
[18] 唐军海,徐庆福,朱潇鹏.IDH1/2突变诱导脑胶质瘤基因组高甲基化及肿瘤细胞分化阻滞[J].国际神经病学神经外科学杂志,2014,41(3):246-249.
[19] 吕晶,赵晓平,范小璇,等.赵晓平基于“虚瘀毒损”治疗脑胶质瘤术后复发经验[J].陕西中医,2024,45(7):955-958.
[20] 张家伟,华锋,唐文艳.血清MMPs及TIMPs检测对神经胶质瘤诊断意义及介入治疗预后判定分析[J].陕西医学杂志,2020,49(11):1507-1509,1514.
[21] 张林娟,李静,郭星.脑胶质瘤手术治疗效果及术后复发的危险因素研究[J].实用癌症杂志,2022,37(9):1451-1453,1461.
[22] 陈家洛,丁涟沭.免疫靶向治疗及手术治疗在脑部肿瘤的研究进展[J].中国临床医生杂志,2021,49(5):526-529.
[23] SILVERMAN D A,MARTINEZ V K,DOUGHERTY P M,et al.Cancer-Associated neurogenesis and Nerve-Cancer Cross-talk[J].Cancer Res,2021,81(6):1431-1440.
[24] 马凯明,杨军.脑胶质瘤瘤周水肿区细胞外间隙改变及机制研究进展[J].中华神经医学杂志,2022,21(3):242-248.

相似文献/References:

[1]罗国强,秦彦昌,张百平,等.长链非编码RNA-ATB在胶质瘤中的表达水平和临床意义[J].陕西医学杂志,2019,(7):831.
　LUO Guoqiang,QIN Yanchang,ZHANG Baiping,et al.Expression level and clinical significance of long non-coding RNA ATB in gastric cancer[J].,2019,(1):831.
[2]冯 健,邓挚玺△.右美托咪定联合舒芬太尼与右美托咪定联合地佐辛〖JZ〗用于胶质瘤患者术后镇痛临床研究*[J].陕西医学杂志,2019,(10):1289.
[3]谢江涛,冯乐宵,王世锋,等.常氧及低氧条件下SHG-44胶质瘤细胞中活性氧及低氧诱导因子-1α的表达及意义[J].陕西医学杂志,2021,50(11):1345.[doi:DOI:10.3969/j.issn.1000-7377.2021.11.006]
　XIE Jiangtao,FENG Lexiao,WANG Shifeng,et al.Expression and significance of reactive oxygen species and hypoxia-inducible factor-1α in SHG-44 glioma cells under normoxia and hypoxia[J].,2021,50(1):1345.[doi:DOI:10.3969/j.issn.1000-7377.2021.11.006]
[4]陈 隆,张玉富.胶质瘤中Circular RNA PRKCI的表达及预后相关影响因素研究[J].陕西医学杂志,2021,50(11):1449.[doi:DOI:10.3969/j.issn.1000-7377.2021.11.032]
　CHEN Long,ZHANG Yufu.Expression of circular RNA PRKCI in glioma and related factors of prognosis[J].,2021,50(1):1449.[doi:DOI:10.3969/j.issn.1000-7377.2021.11.032]
[5]张 昕,赵 千,王丹丹,等.嗅觉受体家族2亚家族W成员3和增殖细胞核抗原在胶质瘤中的表达及相关性研究[J].陕西医学杂志,2023,52(2):196.[doi:DOI:10.3969/j.issn.1000-7377.2023.02.018]
　ZHANG Xin,ZHAO Qian,WANG Dandan,et al.Expression and correlation of olfactory receptor family 2 subfamily W member 3 and proliferating cell nuclear antigen in gliomas[J].,2023,52(1):196.[doi:DOI:10.3969/j.issn.1000-7377.2023.02.018]

备注/Memo

备注/Memo:
基金项目:江苏省重点实验室开放课题(XZSYSKF2021044)
更新日期/Last Update: 2025-01-06